Aurelia de Pauw
Corporate Officer/Principal bei TETRA BIO-PHARMA INC.
Aktive Positionen von Aurelia de Pauw
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 01.10.2018 | - |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Aurelia de Pauw
Ausbildung von Aurelia de Pauw
| Faculté Universitaire des Sciences Agronomiques de Gembloux | Graduate Degree |
| Université de Namur ASBL | Doctorate Degree |
Statistik
International
| Kanada | 3 |
| Belgien | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Börse
- Insiders
- Aurelia de Pauw
- Erfahrung